Blastomycosis: New Insights into Diagnosis, Prevention, and Treatment

Clinics in Chest Medicine

Volumn 30, Issue 2, 2009, Pages 227-239

  McKinnell, James A ^a   Pappas, Peter G ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Antifungal agents therapeutic use; Blastomyces adhesion 1; Blastomyces dermatitidis; Blastomycosis; Endemic mycosis; Vaccine

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; FUNGUS VACCINE; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; VORICONAZOLE;

BLASTOMYCOSIS; CELLULAR IMMUNITY; CLINICAL FEATURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGUS CULTURE; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; MORTALITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SEROLOGY; UNSPECIFIED SIDE EFFECT;

BLASTOMYCOSIS; HUMANS;

EID: 64249151777     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2009.02.003     Document Type: Review

References (159)

1. Gilchrist T.C. Protozoan dermatitis. J Cutan Genitourin Dis 12 (1894) 496-499
2. Gilchrist T.C., and Stokes W.R. The presenece of an Oidium in the tissues of a case of pseudolupus vulgaris. Bull Johns Hopkins Hosp 7 (1896) 129-133
3. Gilchrist T.C., and Stokes W.R. A case of pseudolupus caused by blastomyces. J Exp Med 3 (1898) 53-78
4. Martin D.S., and Smith D.T. Blastomycosis. Am Rev Tuberc 39 (1939) 275-304 488-515
5. Schwarz J., and Baum G.L. Blastomycosis. Am J Clin Pathol 21 (1951) 999-1029
6. Christie A., and Peterson J.C. Pulmonary calcifications in negative reactors to tuberculin. Am J Public Health 35 (1945) 1131-1147
7. Parsons R.J., and Zaronfontis C.J.D. Histoplasmosis in man: report of 7 cases and a review of 71 cases. Arch Intern Med 75 (1945) 1-23
8. Valdivia L., Nix D., Wright M., et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis 12 (2006) 958-962
9. Denton J.F., and Disalvo A.F. Isolation of Blastomyces dermatitidis from natural sites at Augusta, Georgia. Am J Trop Med Hyg 13 (1964) 716-722
10. Baumgardner D.J., and Paretsky D.P. The in vitro isolation of Blastomyces dermatitidis from a woodpile in north central Wisconsin, USA. Med Mycol 37 (1999) 163-168
11. Bakerspigel A., Kane J., and Schaus D. Isolation of Blastomyces dermatitidis from an earthen floor in southwestern Ontario, Canada. J Clin Microbiol 24 (1986) 890-891
12. Sarosi G.A., and Serstock D.S. Isolation of Blastomyces dermatitidis from pigeon manure. Am Rev Respir Dis 114 (1976) 1179-1183
13. Klein B.S., Vergeront J.M., DiSalvo A.F., et al. Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways. Am Rev Respir Dis 136 (1987) 1333-1338
14. Klein B.S., Vergeront J.M., Weeks R.J., et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med 314 (1986) 529-534
15. Sarosi G.A., and Davies S.F. Blastomycosis. Am Rev Respir Dis 120 (1979) 911-938
16. Klein B.S., Vergeront J.M., and Davis J.P. Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis. Semin Respir Infect 1 (1986) 29-39
17. De Groote M.A., Bjerke R., Smith H., et al. Expanding epidemiology of blastomycosis: clinical features and investigation of 2 cases in Colorado. Clin Infect Dis 30 (2000) 582-584
18. Pappas P.G., and Dismukes W.E. Blastomycosis: Gilchrist's disease revisited. Curr Clin Top Infect Dis 22 (2002) 61-77
19. Dworkin M.S., Duckro A.N., Proia L., et al. The epidemiology of blastomycosis in Illinois and factors associated with death. Clin Infect Dis 41 (2005) e107-e111
20. Furcolow M.L., Chick E.W., Busey J.F., et al. Prevalence and incidence studies of human and canine blastomycosis. 1. Cases in the United States, 1885-1968. Am Rev Respir Dis 102 (1970) 60-67
21. Furcolow M.L., Busey J.F., Menges R.W., et al. Prevalence and incidence studies of human and canine blastomycosis. II. Yearly incidence studies in three selected states, 1960-1967. Am J Epidemiol 92 (1970) 121-131
22. Cano M.V., Ponce-de-Leon G.F., Tippen S., et al. Blastomycosis in Missouri: epidemiology and risk factors for endemic disease. Epidemiol Infect 131 (2003) 907-914
23. Chu J.H., Feudtner C., Heydon K., et al. Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis 42 (2006) 822-825
24. Baumgardner D.J., and Brockman K. Epidemiology of human blastomycosis in Vilas County, Wisconsin. II: 1991-1996. WMJ 97 (1998) 44-47
25. Morris S.K., Brophy J., Richardson S.E., et al. Blastomycosis in Ontario, 1994-2003. Emerg Infect Dis 12 (2006) 274-279
26. The Centers for Disease Control and Prevention. Blastomycosis-Wisconsin, 1986-1995. MMWR Morb Mortal Wkly Rep 45 (1996) 601-603
27. Dwight P.J., Naus M., Sarsfield P., et al. An outbreak of human blastomycosis: the epidemiology of blastomycosis in the Kenora catchment region of Ontario, Canada. Can Commun Dis Rep 26 (2000) 82-91
28. Bradsher R.W. Water and blastomycosis: don't blame beaver. Am Rev Respir Dis 136 (1987) 1324-1326
29. Catherinot E., Rivaud E., Epardeau B., et al. A holiday in Canada. Lancet 360 (2002) 1564
30. Parmar M.S. Paradise - not without its plagues: overwhelming Blastomycosis pneumonia after visit to lakeside cottages in Northeastern Ontario. BMC Infect Dis 5 (2005) 30
31. Vaaler A.K., Bradsher R.W., and Davies S.F. Evidence of subclinical blastomycosis in forestry workers in northern Minnesota and northern Wisconsin. Am J Med 89 (1990) 470-476
32. Cockerill III F.R., Roberts G.D., Rosenblatt J.E., et al. Epidemic of pulmonary blastomycosis (Namekagon fever) in Wisconsin canoeists. Chest 86 (1984) 688-692
33. Klein B.S., Vergeront J.M., Kaufman L., et al. Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin. J Infect Dis 155 (1987) 262-268
34. Reed K.D., Meece J.K., Archer J.R., et al. Ecologic niche modeling of Blastomyces dermatitidis in Wisconsin. PLoS ONE 3 (2008) e2034
35. Baumgardner D.J., Steber D., Glazier R., et al. Geographic information system analysis of blastomycosis in northern Wisconsin, USA: waterways and soil. Med Mycol 43 (2005) 117-125
36. Baumgardner D.J., Knavel E.M., Steber D., et al. Geographic distribution of human blastomycosis cases in Milwaukee, Wisconsin, USA: association with urban watersheds. Mycopathologia 161 (2006) 275-282
37. O'Neill R.P., and Penman R.W. Clinical aspects of blastomycosis. Thorax 25 (1970) 708-715
38. Wilson J.W., Cawley E.P., Weidman F.D., et al. Primary cutaneous North American blastomycosis. AMA Arch Derm 71 (1955) 39-45
39. Sugar A.M., and Picard M. Macrophage- and oxidant-mediated inhibition of the ability of live Blastomyces dermatitidis conidia to transform to the pathogenic yeast phase: implications for the pathogenesis of dimorphic fungal infections. J Infect Dis 163 (1991) 371-375
40. Lekkala M., LeVine A.M., Linke M.J., et al. Effect of lung surfactant collectins on bronchoalveolar macrophage interaction with Blastomyces dermatitidis: inhibition of tumor necrosis factor alpha production by surfactant protein D. Infect Immun 74 (2006) 4549-4556
41. Chang W.L., Audet R.G., Aizenstein B.D., et al. T-cell epitopes and human leukocyte antigen restriction elements of an immunodominant antigen of Blastomyces dermatitidis. Infect Immun 68 (2000) 502-510
42. Deepe Jr. G.S., Wuthrich M., and Klein B.S. Progress in vaccination for histoplasmosis and blastomycosis: coping with cellular immunity. Med Mycol 43 (2005) 381-389
43. Klein B.S., Sondel P.M., and Jones J.M. WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis. Infect Immun 60 (1992) 4291-4300
44. Klein B.S., and Jones J.M. Isolation, purification, and radiolabeling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients. J Clin Invest 85 (1990) 152-161
45. Brandhorst T., Wuthrich M., Finkel-Jimenez B., et al. A C-terminal EGF-like domain governs BAD1 localization to the yeast surface and fungal adherence to phagocytes, but is dispensable in immune modulation and pathogenicity of Blastomyces dermatitidis. Mol Microbiol 48 (2003) 53-65
46. Brandhorst T., and Klein B. Cell wall biogenesis of Blastomyces dermatitidis. Evidence for a novel mechanism of cell surface localization of a virulence-associated adhesin via extracellular release and reassociation with cell wall chitin. J Biol Chem 275 (2000) 7925-7934
47. Hogan L.H., Josvai S., and Klein B.S. Genomic cloning, characterization, and functional analysis of the major surface adhesin WI-1 on Blastomyces dermatitidis yeasts. J Biol Chem 270 (1995) 30725-30732
48. Wiedemann A., Linder S., Grassl G., et al. Yersinia enterocolitica invasin triggers phagocytosis via beta1 integrins, CDC42Hs and WASp in macrophages. Cell Microbiol 3 (2001) 693-702
49. Finkel-Jimenez B., Wuthrich M., Brandhorst T., et al. The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis. J Immunol 166 (2001) 2665-2673
50. Finkel-Jimenez B., Wuthrich M., and Klein B.S. BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-alpha production through TGF-beta-dependent and -independent mechanisms. J Immunol 168 (2002) 5746-5755
51. Wuthrich M., Finkel-Jimenez B., Brandhorst T.T., et al. Analysis of non-adhesive pathogenic mechanisms of BAD1 on Blastomyces dermatitidis. Med Mycol 44 (2006) 41-49
52. Wuthrich M., Chang W.L., and Klein B.S. Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis. Infect Immun 66 (1998) 5443-5449
53. Wuthrich M., and Klein B.S. Investigation of anti-WI-1 adhesin antibody-mediated protection in experimental pulmonary blastomycosis. J Infect Dis 181 (2000) 1720-1728
54. Brandhorst T.T., Wuthrich M., Warner T., et al. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis. J Exp Med 189 (1999) 1207-1216
55. Wuthrich M., Filutowicz H.I., and Klein B.S. Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance. J Clin Invest 106 (2000) 1381-1389
56. Cutler J.E., Deepe Jr. G.S., and Klein B.S. Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol 5 (2007) 13-28
57. Shedlock D.J., and Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300 (2003) 337-339
58. Shen H., Whitmire J.K., Fan X., et al. A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes. J Immunol 170 (2003) 1443-1451
59. Sun J.C., and Bevan M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300 (2003) 339-342
60. Wuthrich M., Filutowicz H.I., Warner T., et al. Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J Immunol 169 (2002) 6969-6976
61. Wuthrich M., Warner T., and Klein B.S. CD28 is required for optimal induction, but not maintenance, of vaccine-induced immunity to Blastomyces dermatitidis. Infect Immun 73 (2005) 7436-7441
62. Wuthrich M., Warner T., and Klein B.S. IL-12 is required for induction but not maintenance of protective, memory responses to Blastomyces dermatitidis: implications for vaccine development in immune-deficient hosts. J Immunol 175 (2005) 5288-5297
63. Wuthrich M., Fisette P.L., Filutowicz H.I., et al. Differential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis. J Immunol 176 (2006) 5538-5547
64. Recht L.D., Philips J.R., Eckman M.R., et al. Self-limited blastomycosis: a report of thirteen cases. Am Rev Respir Dis 120 (1979) 1109-1112
65. Tosh F.E., Hammerman K.J., Weeks R.J., et al. A common source epidemic of North American blastomycosis. Am Rev Respir Dis 109 (1974) 525-529
66. Lemos L.B., Baliga M., and Guo M. Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature. Ann Diagn Pathol 5 (2001) 1-9
67. Meyer K.C., McManus E.J., and Maki D.G. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med 329 (1993) 1231-1236
68. Gauthier G.M., Safdar N., Klein B.S., et al. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis 9 (2007) 310-317
69. Vasquez J.E., Mehta J.B., Agrawal R., et al. Blastomycosis in northeast Tennessee. Chest 114 (1998) 436-443
70. Abernathy R.S. Clinical manifestations of pulmonary blastomycosis. Ann Intern Med 51 (1959) 707-727
71. Bradsher R.W. Clinical features of blastomycosis. Semin Respir Infect 12 (1997) 229-234
72. Bradsher R.W., Chapman S.W., and Pappas P.G. Blastomycosis. Infect Dis Clin North Am 17 (2003) 21-40 vii
73. Lemos L.B., Baliga M., and Guo M. Blastomycosis: The great pretender can also be an opportunist. Initial clinical diagnosis and underlying diseases in 123 patients. Ann Diagn Pathol 6 (2002) 194-203
74. Kwon-Chung K.J., and Bennett J.E. Medical mycology (1992), Lea & Febiger, Philadelphia
75. Sarosi G.A., Davies S.F., and Phillips J.R. Self-limited blastomycosis: a report of 39 cases. Semin Respir Infect 1 (1986) 40-44
76. Brown L.R., Swensen S.J., Van Scoy R.E., et al. Roentgenologic features of pulmonary blastomycosis. Mayo Clin Proc 66 (1991) 29-38
77. Halvorsen R.A., Duncan J.D., Merten D.F., et al. Pulmonary blastomycosis: radiologic manifestations. Radiology 150 (1984) 1-5
78. Witorsch P., and Utz J.P. North American blastomycosis: a study of 40 patients. Medicine (Baltimore) 47 (1968) 169-200
79. Moore R.M., and Green N.E. Blastomycosis of bone. A report of six cases. J Bone Joint Surg Am 64 (1982) 1097-1101
80. Chapman S.W., Lin A.C., Hendricks K.A., et al. Endemic blastomycosis in Mississippi: epidemiological and clinical studies. Semin Respir Infect 12 (1997) 219-228
81. Pariseau B., Lucarelli M.J., and Appen R.E. A concise history of ophthalmic blastomycosis. Ophthalmology 114 (2007) e27-e32
82. Gottlieb J.R., and Eismont F.J. Nonoperative treatment of vertebral blastomycosis osteomyelitis associated with paraspinal abscess and cord compression. A case report. J Bone Joint Surg Am 88 (2006) 854-856
83. Pappas P.G., Threlkeld M.G., Bedsole G.D., et al. Blastomycosis in immunocompromised patients. Medicine (Baltimore) 72 (1993) 311-325
84. Butka B.J., Bennett S.R., and Johnson A.C. Disseminated inoculation blastomycosis in a renal transplant recipient. Am Rev Respir Dis 130 (1984) 1180-1183
85. Hii J.H., Legault L., DeVeber G., et al. Successful treatment of systemic blastomycosis with high-dose ketoconazole in a renal transplant recipient. Am J Kidney Dis 15 (1990) 595-597
86. Linden P., Williams P., and Chan K.M. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections. Clin Transplant 14 (2000) 329-339
87. Pechan W.B., Novick A.C., Lalli A., et al. Pulomary nodules in a renal transplant recipient. J Urol 124 (1980) 111-114
88. Serody J.S., Mill M.R., Detterbeck F.C., et al. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis 16 (1993) 54-58
89. Walker K., Skelton H., and Smith K. Cutaneous lesions showing giant yeast forms of Blastomyces dermatitidis. J Cutan Pathol 29 (2002) 616-618
90. Winkler S., Stanek G., Hubsch P., et al. Pneumonia due to blastomyces dermatitidis in a European renal transplant recipient. Nephrol Dial Transplant 11 (1996) 1376-1379
91. Isotalo P.A., Ford J.C., and Veinot J.P. Miliary blastomycosis developing in an immunocompromised host with chronic lymphocytic leukaemia. Pathology 34 (2002) 293-295
92. Kauffman C.A. Endemic mycoses in patients with hematologic malignancies. Semin Respir Infect 17 (2002) 106-112
93. Pappas P.G., Pottage J.C., Powderly W.G., et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 116 (1992) 847-853
94. Lemos L.B., Soofi M., and Amir E. Blastomycosis and pregnancy. Ann Diagn Pathol 6 (2002) 211-215
95. Ismail M.A., and Lerner S.A. Disseminated blastomycosis in a pregnant woman: review of amphotericin B usage during pregnancy. Am Rev Respir Dis 126 (1982) 350-353
96. Tuthill S.W. Disseminated blastomycosis with intrauterine transmission. South Med J 78 (1985) 1526-1527
97. Maxson S., Miller S.F., Tryka A.F., et al. Perinatal blastomycosis: a review. Pediatr Infect Dis J 11 (1992) 760-763
98. MacDonald D., and Alguire P.C. Adult respiratory distress syndrome due to blastomycosis during pregnancy. Chest 98 (1990) 1527-1528
99. Young L., and Schutze G.E. Perinatal blastomycosis: the rest of the story. Pediatr Infect Dis J 14 (1995) 83
100. Martynowicz M.A., and Prakash U.B. Pulmonary blastomycosis: an appraisal of diagnostic techniques. Chest 121 (2002) 768-773
101. Kappe R., Okeke C.N., Fauser C., et al. Molecular probes for the detection of pathogenic fungi in the presence of human tissue. J Med Microbiol 47 (1998) 811-820
102. Bialek R., Gonzalez G.M., Begerow D., et al. Coccidioidomycosis and blastomycosis: advances in molecular diagnosis. FEMS Immunol Med Microbiol 45 (2005) 355-360
103. Bradsher R.W., and Pappas P.G. Detection of specific antibodies in human blastomycosis by enzyme immunoassay. South Med J 88 (1995) 1256-1259
104. Lambert R.S., and George R.B. Evaluation of enzyme immunoassay as a rapid screening test for histoplasmosis and blastomycosis. Am Rev Respir Dis 136 (1987) 316-319
105. Lo C.Y., and Notenboom R.H. A new enzyme immunoassay specific for blastomycosis. Am Rev Respir Dis 141 (1990) 84-88
106. Kaufman L., McLaughlin D.W., Clark M.J., et al. Specific immunodiffusion test for blastomycosis. Appl Microbiol 26 (1973) 244-247
107. Martin D.S. Serologic studies on North American blastomycosis; studies with soluble antigens from untreated and sonic-treated yeast-phase cells of Blastomyces dermatitidis. J Immunol 71 (1953) 192-201
108. Green J.H., Harrell W.K., Johnson J.E., et al. Preparation of reference antisera for laboratory diagnosis of blastomycosis. J Clin Microbiol 10 (1979) 1-7
109. Klein B.S., and Jones J.M. Purification and characterization of the major antigen WI-1 from Blastomyces dermatitidis yeasts and immunological comparison with A antigen. Infect Immun 62 (1994) 3890-3900
110. Soufleris A.J., Klein B.S., Courtney B.T., et al. Utility of anti-WI-1 serological testing in the diagnosis of blastomycosis in Wisconsin residents. Clin Infect Dis 19 (1994) 87-92
111. Durkin M., Witt J., Lemonte A., et al. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 42 (2004) 4873-4875
112. Shurley J.F., Legendre A.M., and Scalarone G.M. Blastomyces dermatitidis antigen detection in urine specimens from dogs with blastomycosis using a competitive binding inhibition ELISA. Mycopathologia 160 (2005) 137-142
113. Spector D., Legendre A.M., Wheat J., et al. Antigen and antibody testing for the diagnosis of blastomycosis in dogs. J Vet Intern Med 22 (2008) 839-843
114. Tarr M., Marcinak J., Mongkolrattanothai K., et al. Blastomyces antigen detection for monitoring progression of blastomycosis in a pregnant adolescent. Infect Dis Obstet Gynecol (2007) [article 89059]
115. Mongkolrattanothai K., Peev M., Wheat L.J., et al. Urine antigen detection of blastomycosis in pediatric patients. Pediatr Infect Dis J 25 (2006) 1076-1078
116. Shurley J.F., and Scalarone G.M. Isoelectric focusing and ELISA evaluation of a Blastomyces dermatitidis human isolate. Mycopathologia 164 (2007) 73-76
117. Hage C.A., Davis T.E., Egan L., et al. Diagnosis of pulmonary histoplasmosis and blastomycosis by detection of antigen in bronchoalveolar lavage fluid using an improved second-generation enzyme-linked immunoassay. Respir Med 101 (2007) 43-47
118. Chapman S.W., Dismukes W.E., Proia L.A., et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 46 (2008) 1801-1812
119. Bradsher Jr. R.W. Pulmonary blastomycosis. Semin Respir Crit Care Med 29 (2008) 174-181
120. Parker J.D., Doto I.L., and Tosh F.E. A decade of experience with blastomycosis and its treatment with amphotericin B. A National Communicable Disease Center Cooperative Mycoses Study. Am Rev Respir Dis 99 (1969) 895-902
121. Bradsher R.W. Histoplasmosis and blastomycosis. Clin Infect Dis 22 Suppl 2 (1996) S102-S111
122. Friedman J.A., Wijdicks E.F., Fulgham J.R., et al. Meningoencephalitis due to Blastomyces dermatitidis: case report and literature review. Mayo Clin Proc 75 (2000) 403-408
123. Abernathy R.S. Amphotericin therapy of North American blastomycosis. Antimicrobial Agents Chemother (Bethesda) 6 (1966) 208-211
124. Clemons K.V., and Stevens D.A. Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosis. Antimicrobial Agents Chemother 35 (1991) 2144-2146
125. Cook P.P. Amphotericin B lipid complex for the treatment of recurrent blastomycosis of the brain in a patient previously treated with itraconazole. South Med J 94 (2001) 548-549
126. Perfect J.R. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis 40 Suppl 6 (2005) S401-S408
127. Panicker J., Walsh T., and Kamani N. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole. Pediatr Infect Dis J 25 (2006) 377-379
128. Chowfin A., Tight R., and Mitchell S. Recurrent blastomycosis of the central nervous system: case report and review. Clin Infect Dis 30 (2000) 969-971
129. Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Ann Intern Med 103 (1985) 861-872
130. Bradsher R.W., Rice D.C., and Abernathy R.S. Ketoconazole therapy for endemic blastomycosis. Ann Intern Med 103 (1985) 872-879
131. Pappas P.G., Bradsher R.W., Chapman S.W., et al. Treatment of blastomycosis with fluconazole: a pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 20 (1995) 267-271
132. Pappas P.G., Bradsher R.W., Kauffman C.A., et al. Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 25 (1997) 200-205
133. Galgiani J.N., Ampel N.M., Blair J.E., et al. Coccidioidomycosis. Clin Infect Dis 41 (2005) 1217-1223
134. Dismukes W.E., Bradsher Jr. R.W., Cloud G.C., et al. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med 93 (1992) 489-497
135. Barone J.A., Koh J.G., Bierman R.H., et al. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicrobial Agents Chemother 37 (1993) 778-784
136. Cartledge J.D., Midgely J., and Gazzard B.G. Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis. J Clin Pathol 50 (1997) 477-480
137. Hardin T.C., Graybill J.R., Fetchick R., et al. Pharmacokinetics of itraconazole following oral administration to normal volunteers. Antimicrobial Agents Chemother 32 (1988) 1310-1313
138. Poirier J.M., Berlioz F., Isnard F., et al. Marked intra- and inter-patient variability of itraconazole steady state plasma concentrations. Therapie 51 (1996) 163-167
139. Stevens D.A. Itraconazole in cyclodextrin solution. Pharmacotherapy 19 (1999) 603-611
140. Barone J.A., Moskovitz B.L., Guarnieri J., et al. Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers. Antimicrobial Agents Chemother 42 (1998) 1862-1865
141. Huet E., Hadji C., Hulin A., et al. Therapeutic monitoring is necessary for the association itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosis. AIDS 22 (2008) 1885-1886
142. Koo H.L., Hamill R.J., and Andrade R.A. Drug-drug interaction between itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosis. Clin Infect Dis 45 (2007) e77-e79
143. Li R.K., Ciblak M.A., Nordoff N., et al. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrobial Agents Chemother 44 (2000) 1734-1736
144. Espinel-Ingroff A. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 36 (1998) 2950-2956
145. Sugar A.M., and Liu X.P. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Antimicrobial Agents Chemother 40 (1996) 1314-1316
146. Sugar A.M., and Liu X.P. Efficacy of voriconazole in treatment of murine pulmonary blastomycosis. Antimicrobial Agents Chemother 45 (2001) 601-604
147. Lutsar I., Roffey S., and Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis 37 (2003) 728-732
148. Bakleh M., Aksamit A.J., Tleyjeh I.M., et al. Successful treatment of cerebral blastomycosis with voriconazole. Clin Infect Dis 40 (2005) e69-e71
149. Borgia S.M., Fuller J.D., Sarabia A., et al. Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen. Med Mycol 44 (2006) 659-664
150. Lemos L.B., Guo M., and Baliga M. Blastomycosis: organ involvement and etiologic diagnosis. A review of 123 patients from Mississippi. Ann Diagn Pathol 4 (2000) 391-406
151. Groll A.H., Giri N., Petraitis V., et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis 182 (2000) 274-282
152. Harley W.B., Lomis M., and Haas D.W. Marked polymorphonuclear pleocytosis due to blastomycotic meningitis: case report and review. Clin Infect Dis 18 (1994) 816-818
153. Pearson G.J., Chin T.W., and Fong I.W. Case report: treatment of blastomycosis with fluconazole. Am J Med Sci 303 (1992) 313-315
154. Taillan B., Ferrari E., Cosnefroy J.Y., et al. Favourable outcome of blastomycosis of the brain stem with fluconazole and flucytosine treatment. Ann Med 24 (1992) 71-72
155. Johnson L.B., and Kauffman C.A. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 36 (2003) 630-637
156. Smith J., Safdar N., Knasinski V., et al. Voriconazole therapeutic drug monitoring. Antimicrobial Agents Chemother 50 (2006) 1570-1572
157. Denning D.W., Ribaud P., Milpied N., et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34 (2002) 563-571
158. Lahm T., Neese S., Thornburg A.T., et al. Corticosteroids for blastomycosis-induced ARDS: a report of two patients and review of the literature. Chest 133 (2008) 1478-1480
159. Abernathy R.S., and Melby J.C. Addison's disease in North American blastomycosis. N Engl J Med 266 (1962) 552-554